Incretin-based therapy and the risk of diabetic foot ulcers and related events. Werkman NCC, Driessen JHM, Klungel OH, Schaper NS, et al. Diabetes Obes Metab 2024 Jul 1. doi: 10.1111/dom.15721.

Read + Share

Amedeo Smart

Independent Medical Education

Werkman NCC, Driessen JHM, Klungel OH, Schaper NS, et al. Incretin-based therapy and the risk of diabetic foot ulcers and related events. Diabetes Obes Metab 2024 Jul 1. doi: 10.1111/dom.15721.
PMID: 38951877